ArticleBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2014

Treatment with a rho kinase inhibitor improves survival from graft-versus-host disease in mice after MHC-haploidentical hematopoietic cell transplantation.

Sujatha Iyengar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.